UPDATE: The PSOLVE+ community on Sosido wrapped up at the end of June 2022; members received their final PSOLVE+ Sosido email digest on Wednesday, June 29. Thank you to Novartis Canada for their generous support of this initiative.
PSOLVE+ is an online learning community for Canadian physicians with an interest in psoriasis and other dermatological conditions.
PSOLVE+ has been created to sustain a connection amongst Canadian physicians who treat psoriasis and other dermatological conditions, to exchange clinical findings and professional perspectives, promoting the highest level of care in Canada.
Members of PSOLVE+ will receive a weekly email digest with curated articles from sources identified by the PSOLVE+ faculty as well as periodic learning opportunities including online discussions, podcasts, webinars and polls.
LegitiMed will be managing this virtual community residing on Sosido (sosido.com).
Thank you to Novartis Canada for their financial support of this initiative.
The PSOLVE+ community is designed for the scientific exchange of information between Healthcare Professionals and is made possible with financial support from Novartis Canada. Novartis does not itself monitor the discussions. However a third-party service provider does review the discussions only for the purpose of identifying any potential AE discussion. This review is required since as a drug manufacturer, Novartis has a regulatory obligation to report any AE that (directly or indirectly) comes to their attention. The third-party will only report the potential AE discussion and will include contact information. Should your post be reported to patient safety, you will be contacted by the third-party service provider to determine if you would like Novartis patient safety to contact you for more details.